Hemophilia A: Therapeutic Updates, Emerging Therapies, and Barriers to Care

Details

This free CME activity will give physicians the latest insights around Hemophilia A and will them better treat patients who are plagued by the disease.

Topics covered in this course includes:

• Updates in the epidemiology and diagnosis of hemophilia A
• Current and emerging treatment options for hemophilia A
• Challenges in care in hemophilia A

After completing this activity, physicians will better be able to:

• Describe the pathophysiology of hemophilia A, with an emphasis on characteristics that play a role in determining the staging, prognosis, and diagnosis
• Describe the benefits of prophylactic vs. on-demand clotting factor regimens in patients with hemophilia and apply them in patient cases
• Describe the emerging therapies in the treatment of hemophilia A
• Individualize treatments in patients with hemophilia A by taking into account treatment modalities, recent clinical trial evidence, and barriers to care , including inhibitors

Target Audience: Hematology, primary care physicians, and pediatricians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in hematology; and any other clinicians with an interest in hemophilia A.